CHA sent a letter to the DEA supporting their policy change to better address children’s unique health care needs. CHA has advocated that the DEA maintain access to care for children via telehealth and reiterated our support for the special registration process in our letter. The DEA will have another comment period this fall before the telemedicine rules are finalized.
CHA Sends Letter to DEA on Tele-prescribing for Controlled Substances
Related Content
Resources for IV Fluid Mitigation
CHA is sharing information from children’s hospitals and industry experts to help address IV fluid disruption in the wake of Hurricane Helene.
CHA Submits Letter to HHS on Baxter Closure
The letter thanks HHS for their response to supply shortages caused by Hurricane Helene and urges continued support for pediatric needs during ongoing IV solution shortages.
High-Cost Therapies for Pediatrics
Pediatric HCTs are innovative and lifesaving or life-altering treatments for children with chronic, rare, and complex conditions.